NCT06389409 Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients
| NCT ID | NCT06389409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Testicular Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2010-08-24 |
| Primary Completion | 2030-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2010-08-24 with a primary completion date of 2030-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research aims to collect data in order to report the main problems related to the testicular cancer; To reach this aim, this study proposes to create a database of the testicular cancer condition. From this perspective, the aim of this project is the improving of scientific knowledge of the disease and develop appropriate and effective procedures for the diagnosis and treatment of the patient.
Eligibility Criteria
Inclusion Criteria: * subjects suffering from suspected neoplastic testicular pathology candidates for testicle removal surgery * patients suffering from neoplastic testicular pathology requiring removal of the retroperitoneal lymph nodes * subjects \> 18 years old * subjects with at least elementary education * signature of informed consent Exclusion Criteria: * subjects \< 18 years * presence of mental or physical disability that may prevent the patient from satisfying the requirements of the protocol
Contact & Investigator
Andrea Salonia, MD
PRINCIPAL INVESTIGATOR
IRCCS Ospedale San Raffaele
Frequently Asked Questions
Who can join the NCT06389409 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Testicular Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06389409 currently recruiting?
Yes, NCT06389409 is actively recruiting participants. Contact the research team at salonia.andrea@hsr.it for enrollment information.
Where is the NCT06389409 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06389409 clinical trial?
NCT06389409 is sponsored by IRCCS San Raffaele. The principal investigator is Andrea Salonia, MD at IRCCS Ospedale San Raffaele. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.